Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAston Martin Lagonda Regulatory News (AML)

Share Price Information for Aston Martin Lagonda (AML)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 157.00
Bid: 147.00
Ask: 160.00
Change: 0.00 (0.00%)
Spread: 13.00 (8.844%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 157.00
AML Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Announcement re: Rights Issue

30 Mar 2020 17:21

RNS Number : 1164I
Aston Martin Lagonda Global Hld PLC
30 March 2020
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, CHINA OR SOUTH AFRICA.

NOTHING IN THIS ANNOUNCEMENT SHOULD BE INTERPRETED AS A TERM OR CONDITION OF THE RIGHTS ISSUE. ANY DECISION TO PURCHASE, SUBSCRIBE FOR, OTHERWISE ACQUIRE, SELL OR OTHERWISE DISPOSE OF ANY NIL PAID RIGHTS, FULLY PAID RIGHTS OR NEW SHARES MUST BE MADE ONLY ON THE BASIS OF THE INFORMATION CONTAINED IN THE PROSPECTUS TAKEN TOGETHER WITH ANY SUPPLEMENTARY PROSPECTUSES. COPIES OF THE PROSPECTUS DATED 27 FEBRUARY 2020 AND THE FIRST SUPPLEMENTARY PROSPECTUS DATED 13 MARCH 2020 ARE, AND THE SECOND SUPPLEMENTARY PROSPECTUS EXPECTED TO BE PUBLISHED LATER TODAY OR TOMORROW WILL BE FOLLOWING ITS PUBLICATION, AVAILABLE FROM THE REGISTERED OFFICE OF THE COMPANY AND ON ITS WEBSITE AT WWW.ASTONMARTINLAGONDA.COM.

30 March 2020

Aston Martin Lagonda Global Holdings plc

("Aston Martin Lagonda", the "Company" or the "Group")

Aston Martin Lagonda General Meeting approves Equity Placement andRights Issue to raise gross proceeds of £536m

Planned publication of updated supplementary prospectus 

· Lawrence Stroll will join the Aston Martin Lagonda Global Holdings plc Board of Directors as Executive Chairman on 20 April 2020

· Aston Martin will enter an F1TM Works team for the first time since 1950s

· Aston Martin's SUV, DBX on-time for first deliveries to dealers in summer, dependent on production and supply chain returning as currently anticipated

Following today's General Meeting, Aston Martin Lagonda confirms that it will be raising gross capital proceeds of £536m through an equity raise, including a private placement of shares for £171m to the Lawrence Stroll led Yew Tree Consortium (as part of their total investment of £262m) and a subsequent rights issue.

Given the current COVID-19 pandemic, the Company expects later today or tomorrow to publish a second supplementary prospectus which includes additional clarification on working capital, on the basis of the existing ESMA technical guidance. The substantive form of this second supplementary prospectus is reproduced in full below.

Penny Hughes, Aston Martin Lagonda Chair, commented:

 "As outgoing Chair, I'm delighted to welcome Mr Stroll and his consortium partners to the share register and, to Mr Stroll joining the Board from 20 April. Despite the ongoing impact of Covid-19, with extraordinary teamwork we have brought in significant new investment, demonstrating the confidence and belief of these new investors in Aston Martin Lagonda, and ensuring that the Company continues to bring exciting products to market. In the short term the Board believes this will facilitate Aston Martin Lagonda to trade through the current period of unprecedented uncertainty in order to continue the planned transformation of its business. Looking ahead, the launch of the DBX, will mark the Company's entrance to the attractive luxury SUV market."

 

 

Aston Martin Lagonda President and Group CEO, Dr Andy Palmer commented:

 "In these difficult days whilst we are dealing with Covid-19, the primary concern remains the health and safety of employees and their families, business partners and the local communities and the company continues to provide all the support possible. Public health measures advised by governments are being followed in support of their efforts to contain the spread of the virus.

We remain focused, confident and excited about our current and new programmes. The company's first SUV, DBX will start production shortly after returning from the Covid-19 enforced shutdown, with an order book now exceeding 2,000 units and deliveries still planned for summer 2020 (dependent on production and supply chain returning as currently anticipated). We also have a firm forward order book for our core sports cars, which includes strong initial orders for our new Vantage Roadster. Our all new V6 hybrid powertrain is already well advanced in development and will enter production with the Valhalla supercar, followed by the Vanquish mid-engined car in the mid-term."

Lawrence Stroll, incoming Aston Martin Lagonda Executive Chair commented:

"I, and my co-investors in the consortium, continue to believe passionately in the future of Aston Martin Lagonda. This is most clearly demonstrated by our investment of £262m which underpins the financial security of the Company. This is a very significant capital raise of £536m - due to be made by my consortium and other shareholders at a very challenging time. This gives the necessary stability to reset the business for its long-term future. We have a clear plan to make this happen, including Aston Martin entering an F1TM works team next season and I look forward to working with the Management team to deliver this programme."

 

To mitigate these unprecedented times, quick and decisive actions have been taken, which include:

· the temporary suspension of all production at both the Gaydon and St Athan facilities from 25 March 2020;

· staff are now working from home and the process of furloughing employees as appropriate has commenced;

· utilising all Government aid available;

· taking actions to control and re-phase both operating costs (such as marketing) and capital expenditure in order to protect the Company's financial position; and

· renewing and accessing additional funding facilities.

 

Extract from the second supplementary prospectus

Background

COVID-19 has created very significant challenges for companies given its widespread adverse global economic, social and operational impact, the effects of which are continuing to unfold.

The risks associated with COVID-19 were disclosed, in each case as they were known at the time, in the Original Prospectus published on 27 February 2020, and emphasised further in the First Supplementary Prospectus published on 13 March 2020 as the outbreak developed globally, prompting the renegotiation of the terms of the transaction.

Ahead of admission of the Nil Paid Rights to listing and trading, the Directors, having requested that their reporting accountant provide a bring down comfort letter concerning the Directors' working capital statement made in the Original Prospectus, have concluded that such letter could give doubt as to the continued basis for the working capital statement. This doubt is driven by the increased and unquantifiable uncertainty in the current unprecedented environment impacting the ability of the Company to consider an accurately modelled reasonable worse case downside and to conclude that there is very little risk that the working capital statement is subsequently called into question.

The updated statement in relation to working capital set out below constitutes a significant new factor for the purposes of the Prospectus Regulation Rules, requiring the publication of the Second Supplementary Prospectus.

Background to regulatory approach to working capital disclosure

The requirement of the FCA's Prospectus Regulation Rules is for the Company to make a statement that there is sufficient working capital for its present requirements or, if not, how it proposes to provide for the additional working capital needed.

There is guidance in relation to working capital from the European Securities and Markets Authority (ESMA) that sits alongside the Prospectus Regulation Rules. The guidance makes it clear that an issuer has a binary choice - namely that, if it cannot make a 'clean' working capital statement, then it has to make a 'qualified' working capital statement. There is no middle ground.

Accordingly, the working capital disclosure set out below has been included in the Second Supplementary Prospectus in consequence of the ESMA guidance.

Working capital

Taking into account the proceeds of the capital raise, the Company is of the opinion that the Group does not have sufficient working capital to meet its requirements for 12 months following the publication of the Original Prospectus. This is due to the increased impact, since the Company published the First Supplementary Prospectus on 13 March, of Covid-19 and the ongoing and unquantifiable uncertainty it has created and continues to create.

Directors' perspectives

As at the date of the Second Supplementary Prospectus, for the reasons set out below the Directors remain confident of the Company's ability to trade through the current period, subject to the uncertainties related to COVID-19 and, notwithstanding the requirement to update the original unqualified working capital statement as above, remain confident as to the sufficiency of the Group's working capital for at least the next 12 months.

As part of the capital raise process and in light of the developing COVID-19 situation, the Company has run multiple stress tests on the Company's business plan, with the increased size of capital raise and other funding providing additional safeguards to the Company in the short and medium term.

Capital expenditure and discretionary operating costs remain under control and the Company is confident in its ability to adjust these items according to need.

Furthermore, the Company plans to take various mitigating actions available that were not, due to the then prevailing circumstances, considered for the purposes of the working capital exercise conducted prior to publication of the Original Prospectus, and which will, in the opinion of the Directors, provide additional liquidity headroom.

1. The Company has access to additional funding facilities in the aggregate amount of approximately £150 million and include:

a. confirmation of continuing support in respect of the £36.7 million in back to back loan arrangements,

b. £40 million in inventory repurchase arrangements (which continue on a rolling basis of up to 180 days per tranche), and

c. a signed mandate letter in respect of up to $100 million in further inventory financing (which Is expected to be available from early May).

2. Among other mitigating actions already disclosed, the Company retains the option until 8 July 2020 to draw up to $100 million of the Delayed Draw Notes issued on 8 October 2019 (as described in the Prospectus) and is in the process of refinancing its current Wholesale Finance Facility.

3. The Company remains in discussion with the UK government in relation to the potential support packages available to businesses to trade through the pandemic.

4. Alongside this, the Company continues to review all future funding and refinancing options.

The current order book for Aston Martin vehicles remains significant. Despite the recent enforced closure of the production facilities, the Company has an established supply chain and continues to work with its suppliers and business partners to be ready to deliver production to meet demand as soon as it is able to reopen its production facilities.

In light of, and subject to, the mitigating actions set out above, the Directors remain confident that the Group will have sufficient working capital for at least the next 12 months.

The expected timetable for the Rights Issue and the Placing as set forth in the First Supplementary Prospectus will not change as a result of the publication of the Second Supplementary Prospectus.

 

This announcement should be read in conjunction with the Original Prospectus, the First Supplementary Prospectus and, following its expected publication later today or tomorrow, the Second Supplementary Prospectus. Capitalised terms used but not otherwise defined in this announcement have the meanings given to them in the Original Prospectus as supplemented by the First Supplementary Prospectus and, following its expected publication later today or tomorrow, the Second Supplementary Prospectus. The Original Prospectus and First Supplementary Prospectus are, and the Second Supplementary Prospectus will following its publication be, available on the Company's website (www.astonmartinlagonda.com/investors).

The financial information contained herein is unaudited and certain financial data within this announcement have been rounded.

 

 

Enquiries

Investors and Analysts

Charlotte Cowley Director of Investor Relations +44 (0)7771 976764

charlotte.cowley@astonmartin.com

Media

Kevin Watters Director of Communications +44 (0)7764 386683

kevin.watters@astonmartin.com

Toby Bates Senior Adviser, Financial Communications +44 (0)7584 773837

toby.bates1@astonmartin.com

Grace Barnie Corporate Communication Manager +44 (0)7880 903490

grace.barnie@astonmartin.com

Brunswick

Dan Roberts, Diana Vaughton +44 (0)20 7404 5959 astonmartin@brunswickgroup.com

 

 

Morgan Stanley (Sole Financial Adviser, Sponsor & Joint Global Co-ordinator & Bookrunner)Andrew Foster +44 (0)20 7425 8000

Mark Rawlinson

Anthony Zammit

Martin Thorneycroft

 

Deutsche Bank (Joint Corporate Broker, Joint Global Co-ordinator & Bookrunner)

Matt Hall +44 (0)20 7545 8000

Saadi Soudavar

Reinhard Kuehn

Mark Hankinson

 

J.P. Morgan Cazenove (Joint Corporate Broker, Joint Global Co-ordinator & Bookrunner)

Robert Constant +44 (0)20 7742 4000

Virginia Khoo

Luca Santini

Alex Watkins

 

 

Tulchan Communications(Communications Adviser to the Consortium) +44 (0)20 7353 4200

Martin Robinson, Simon Pilkington, Harry Cameron

 

Barclays (Financial Adviser to Yew Tree Overseas Limited) +44 (0)20 7623 2323

Derek Shakespeare

Enrico Chiapparoli

Gaurav Gooptu

Darren Johnson

 

IMPORTANT NOTICE

This announcement has been issued by and is the sole responsibility of the Company. The information contained in this announcement is for background purposes only and does not purport to be full or complete. No reliance may or should be placed by any person for any purpose whatsoever on the information contained in this announcement or on its accuracy or completeness. The information in this announcement is subject to change.

This announcement is not a prospectus but an advertisement. Neither this announcement nor anything contained in it shall form the basis of, or be relied upon in conjunction with, any offer or commitment whatsoever in any jurisdiction. Investors should not acquire any Nil Paid Rights, Fully Paid Rights or New Shares referred to in this announcement except on the basis of the information contained in the combined prospectus and circular dated 27 February 2020 (the "Original Prospectus") as supplemented by the supplementary combined prospectus and circular dated 13 March 2020 (the "First Supplementary Prospectus") and, following its expected publication later today or tomorrow, the second supplementary prospectus (the "Second Supplementary Prospectus") published by the Company in connection with the Rights Issue.

Copies of the Original Prospectus and the First Supplementary Prospectus are, and copies of the Second Supplementary Prospectus will following publication be, available from the registered office of the Company and on its website at www.astonmartinlagonda.com. Neither the content of the Company's website nor any website accessible by hyperlinks on the Company's website is incorporated in, or forms part of, this announcement. The Original Prospectus and First Supplementary Prospectus provide, and the Second Supplementary Prospectus will following publication provide, further details of the New Shares, the Nil Paid Rights and the Fully Paid Rights being offered pursuant to the Rights Issue.

This announcement does not contain or constitute an offer for sale or the solicitation of an offer to purchase securities in the United States. The Nil Paid Rights, the Fully Paid Rights, the New Shares and the Provisional Allotment Letters have not been and will not be registered under the US Securities Act of 1933 (the "Securities Act") or under any securities laws of any state or other jurisdiction of the United States and may not be offered, sold, taken up, exercised, resold, renounced, transferred or delivered, directly or indirectly, within the United States except pursuant to an applicable exemption from or in a transaction not subject to the registration requirements of the Securities Act and in compliance with any applicable securities laws of any state or other jurisdiction of the United States. There will be no public offer of the Nil Paid Rights, the Fully Paid Rights or the New Shares in the United States. Subject to certain limited exceptions, Provisional Allotment Letters have not been, and will not be, sent to, and Nil Paid Rights have not been and will not be credited to the CREST account of, any Qualifying Shareholder with a registered address in or that is located in the United States. None of the New Shares, the Nil Paid Rights, the Fully Paid Rights, Provisional Allotment Letters or the Form of Proxy, this announcement or any other document connected with the Rights Issue has been or will be approved or disapproved by the United States Securities and Exchange Commission or by the securities commissions of any state or other jurisdiction of the United States or any other regulatory authority, and none of the foregoing authorities or any securities commission has passed upon or endorsed the merits of the offering of the New Shares, the Nil Paid Rights, the Fully Paid Rights, Provisional Allotment Letters, the Form of Proxy or the accuracy or adequacy of this announcement or any other document connected with the Rights Issue. Any representation to the contrary is a criminal offence in the United States.

This announcement is for information purposes only and is not intended to and does not constitute or form part of any offer or invitation to purchase or subscribe for, or any solicitation to purchase or subscribe for, Nil Paid Rights, Fully Paid Rights or New Shares or to take up any entitlements to Nil Paid Rights in any jurisdiction. No offer or invitation to purchase or subscribe for, or any solicitation to purchase or subscribe for, Nil Paid Rights, Fully Paid Rights or New Shares or to take up any entitlements to Nil Paid Rights will be made in any jurisdiction in which such an offer or solicitation is unlawful. The information contained in this announcement is not for release, publication or distribution to persons in the United States or Australia, Canada, Japan, the People's Republic of China or the Republic of South Africa, and should not be distributed, forwarded to or transmitted in or into any jurisdiction, where to do so might constitute a violation of local securities laws or regulations.

The distribution of this announcement into jurisdictions other than the United Kingdom may be restricted by law, and, therefore, persons into whose possession this announcement comes should inform themselves about and observe any such restrictions. Any failure to comply with any such restrictions may constitute a violation of the securities laws of such jurisdiction. In particular, subject to certain exceptions, this announcement, the Original Prospectus, the First Supplementary Prospectus, the Second Supplementary Prospectus (once published) and the Provisional Allotment Letters (once printed) should not be distributed, forwarded to or transmitted in or into the United States or any other Excluded Territory.

Recipients of this announcement, the Original Prospectus, the First Supplementary Prospectus and/or the Second Supplementary Prospectus should conduct their own investigation, evaluation and analysis of the business, data and property described in this announcement, the Original Prospectus, the First Supplementary Prospectus and/or if and when published the Second Supplementary Prospectus. This announcement does not constitute a recommendation concerning any investor's options with respect to the Rights Issue. The price and value of securities can go down as well as up. Past performance is not a guide to future performance. The contents of this announcement are not to be construed as legal, business, financial or tax advice. Each Shareholder or prospective investor should consult his, her or its own legal adviser, business adviser, financial adviser or tax adviser for legal, financial, business or tax advice.

Notice to all investors

Morgan Stanley & Co. International plc ("Morgan Stanley") is authorised by the Prudential Regulation Authority and regulated by the Prudential Regulation Authority and Financial Conduct Authority. Morgan Stanley is acting for Aston Martin Lagonda Global Holdings plc in relation to the Capital Raise, will not regard any other person as a client in relation to the Placing and Rights Issue and will not be responsible to anyone other than Aston Martin Lagonda Global Holdings plc for providing the protections afforded to clients of Morgan Stanley nor for providing advice to any such other person.

Deutsche Bank AG is authorised under German Banking Law (competent authority: European Central Bank) and, in the United Kingdom, by the Prudential Regulation Authority (the "PRA"). It is subject to supervision by the European Central Bank and by BaFin, Germany's Federal Financial Supervisory Authority, and is subject to limited regulation in the United Kingdom by the PRA and the Financial Conduct Authority (the "FCA"). Details about the extent of its authorisation and regulation by the PRA, and regulation by the FCA, are available on request. Deutsche Bank AG, acting through its London branch ("Deutsche Bank"), is acting for Aston Martin Lagonda and no other person in connection with the Capital Raise. Neither Deutsche Bank, nor any of its subsidiaries, branches or affiliates will be responsible to any person other than Aston Martin Lagonda for providing any of the protections afforded to clients of Deutsche Bank nor for providing advice in relation to the Capital Raise or any matters referred to in this Announcement.

J.P. Morgan Securities plc (which conducts its UK investment banking business as "J.P. Morgan Cazenove") is authorised by the Prudential Regulation Authority and regulated by the Prudential Regulation Authority and Financial Conduct Authority. J.P. Morgan Cazenove is acting for Aston Martin Lagonda Global Holdings plc and no other person in connection with the Capital Raise and will not be responsible to anyone other than Aston Martin Lagonda Global Holdings plc for providing the protections afforded to clients of J.P. Morgan Cazenove nor for providing advice to any person in relation to the Capital Raise or any matters referred to in this announcement.

Barclays Bank PLC, acting through its investment bank ("Barclays"), which is authorised by the Prudential Regulation Authority and regulated in the United Kingdom by the Financial Conduct Authority and the Prudential Regulation Authority, is acting exclusively for Yew Tree Overseas Limited and SHL Capital (UK) Limited and no one else in connection with the transaction referred to herein and will not be responsible to anyone other than Yew Tree Overseas Limited and / or SHL Capital (UK) Limited for providing the protections afforded to clients of Barclays nor for providing advice in relation to the transaction referred to herein or any other matter referred to in this announcement.

None of Morgan Stanley, Deutsche Bank, J.P. Morgan Cazenove or Barclays, nor any of their respective subsidiaries, branches or affiliates, nor any of their respective directors, officers or employees owes or accepts any duty, liability or responsibility whatsoever (whether direct or indirect, whether in contract, in tort, under statute or otherwise) to any person who is not a client of Morgan Stanley, Deutsche Bank, J.P. Morgan Cazenove or Barclays in connection with the Capital Raise, this Announcement, any statement contained herein, or otherwise.

Cautionary statement regarding forward-looking statements

This announcement contains forward-looking statements, including with respect to financial information, that are based on current expectations or beliefs, as well as assumptions about future events. These forward-looking statements can be identified by the fact that they do not relate only to historical or current facts. Forward-looking statements often use words such as "anticipate", "target", "expect", "estimate", "intend", "plan", "goal", "believe", "will", "may", "should", "would", "could", "is confident", or other words of similar meaning. Undue reliance should not be placed on any such statements because they speak only as at the date of this announcement and, by their very nature, they are subject to known and unknown risks and uncertainties and can be affected by other factors that could cause actual results, and the Company's plans and objectives, to differ materially from those expressed or implied in the forward-looking statements. No representation or warranty is made that any forward-looking statement will come to pass.

You are advised to read the Original Prospectus, the First Supplementary Prospectus and, when published, the Second Supplementary Prospectus in their entirety and, in particular, the sections of the Original Prospectus and the First Supplementary Prospectus headed "Risk Factors", for a further discussion of the factors that could affect the Group's future performance and the industry in which it operates. In light of these risks, uncertainties and assumptions, the events described in the forward looking statements, including statements regarding prospective financial information, in this announcement may not occur. These statements are not fact and should not be relied upon as being necessarily indicative of future results, and readers of this announcement are cautioned not to place undue reliance on the forward-looking statements, including those regarding prospective financial information.

No statement in this announcement is intended as a profit forecast, and no statement in this announcement should be interpreted to mean that underlying operating profit for the current or future financial years would necessarily be above a minimum level, or match or exceed the historical published operating profit or set a minimum level of operating profit.

Neither the Company nor any of Morgan Stanley, Deutsche Bank, J.P. Morgan Cazenove or Barclays are under any obligation to update or revise publicly any forward-looking statement contained within this announcement, whether as a result of new information, future events or otherwise, other than in accordance with their legal or regulatory obligations (including, for the avoidance of doubt, the Prospectus Regulation Rules, the Listing Rules and Disclosure Guidance and Transparency Rules).

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ARIEASDEDSDEEFA
Date   Source Headline
8th Apr 20249:00 amRNSAnnual Report 2023 and Notice of AGM
28th Mar 20244:10 pmRNSDirector Declaration
22nd Mar 20248:28 amRNSAppointment of New Chief Executive Officer
13th Mar 20246:16 pmRNSSuccessful pricing of £1.15 billion refinancing
12th Mar 20243:33 pmRNSHolding(s) in Company
11th Mar 20247:36 amRNSLaunch of Notes Offering
4th Mar 20249:05 amRNSIssue of equity to satisfy share awards
28th Feb 20247:00 amRNSPreliminary Results year ended 31 December 2023
20th Dec 20239:32 amRNSHolding(s) in Company
20th Dec 20239:31 amRNSHolding(s) in Company
8th Nov 20233:46 pmRNSHolding(s) in Company
8th Nov 20233:41 pmRNSHolding(s) in Company
8th Nov 20238:00 amRNSHolding(s) in Company
7th Nov 20233:23 pmRNSHolding(s) in Company
3rd Nov 202310:18 amRNSDirector/PDMR Shareholding
2nd Nov 20238:00 amRNSAdmission of shares and total voting rights
1st Nov 20237:00 amRNS3rd Quarter Results
30th Oct 20237:00 amRNSDirectorate Change
3rd Oct 20232:14 pmRNSDirector/PDMR Shareholding
3rd Oct 20232:13 pmRNSDirector/PDMR Shareholding
3rd Oct 20232:10 pmRNSDirector/PDMR Shareholding
3rd Oct 20232:10 pmRNSDirector/PDMR Shareholding
3rd Oct 20232:07 pmRNSHolding(s) in Company
29th Sep 20237:00 amRNSIncreased investment by Yew Tree Consortium
19th Sep 202311:53 amRNSResult of Meeting
29th Aug 202312:01 pmRNSPublication of Circular and Notice of GM
4th Aug 20234:45 pmRNSHolding(s) in Company
4th Aug 20231:05 pmRNSDirector/PDMR Shareholding
4th Aug 202312:43 pmRNSDirector/PDMR Shareholding
4th Aug 202312:33 pmRNSDirector/PDMR Shareholding
4th Aug 202312:32 pmRNSDirector/PDMR Shareholding
4th Aug 202312:21 pmRNSHolding(s) in Company
1st Aug 20237:00 amRNSResult of Equity Issue
31st Jul 20234:41 pmRNSRetail Offer
31st Jul 20234:40 pmRNSProposed Share Placing
28th Jul 20237:00 amRNSAppointment of Non-executive Director
26th Jul 20232:49 pmRNSTotal Voting Rights
26th Jul 20237:00 amRNSHalf-year Report
14th Jul 202312:18 pmRNSHolding(s) in Company
10th Jul 20234:34 pmRNSReplacement Listing and Total Voting Rights
10th Jul 20238:56 amRNSAdditional Listing and Total Voting Rights
6th Jul 20238:16 amRNSHolding(s) in Company
3rd Jul 20237:00 amRNSAdmission of New Shares for Warrant exercise
27th Jun 20237:00 amRNSCapital Markets Day 2023
26th Jun 20237:00 amRNSAston Martin Lagonda and Lucid Group, Inc.
26th Jun 20237:00 amRNSAston Martin Lagonda and Mercedes-Benz AG
31st May 20239:18 amRNSHolding(s) in Company
30th May 202310:44 amRNSHolding(s) in Company
30th May 202310:39 amRNSHolding(s) in Company
30th May 20238:46 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.